Accueil > BIGG > Résultat de la recherche

    Résultats: 4

    Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children

    Lewinsohn, DM; Leonard, MK; LoBue, PA; Cohn, DL; Daley, CL; Desmond, E; Keane, J; Lewinsohn, DA; Loeffler, AM; Mazurek, GH; O'Brien, RJ; Pai, M; Richeldi, L; Salfinger, M; Shinnick, TM; Sterling, TR; Warshauer, DM; Woods, GL.
    Clin Infect Dis.; 64 (2), 2017
    BACKGROUND: Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuberculosis disease) or may have no clinical evidence of disease (latent tuberculosis infection [LTBI]). Tuberculosis disease is a leading cause of infectious disease morbidity and mortality...
    Tuberculose pulmonaire/diagnostic, Tuberculose latente/diagnostic, Sensibilité et spécificité, Mycobacterium tuberculosis/isolement et purification, Tuberculose/diagnostic, Approche GRADE, Test tuberculinique, Reproductibilité des résultats, Tests de libération d'interféron-gamma
    Texte intégral

    Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children. Policy update.

    World Health Organization.
    The global priorities for tuberculosis (TB) care and control are to improve case-detection and to detect cases earlier, including cases of smear-negative disease which are often associated with coinfection with the human immunodeficiency virus (HIV) and young age, and to enhance the capacity to diagnose ...
    Tuberculose multirésistante/diagnostic, Tuberculose/diagnostic, Rifampicine/pharmacologie, Mycobacterium tuberculosis/isolement et purification, Infections à VIH/diagnostic, Sensibilité et spécificité
    Texte intégral

    Noncommercial culture and drug-susceptibility testing methods for screening patients at risk for multidrug-resistant tuberculosis: policy statement

    World Health Organization.
    Commercial liquid culture systems and molecular line-probe assays have been endorsed by the World Health Organization (WHO) as gold standards for rapid detection of multidrug-resistant (MDR) tuberculosis (TB); however, because of technical complexity, cost and the requirement for sophisticated laboratory...
    Tuberculose multirésistante, Antituberculeux, Tests de sensibilité microbienne, Mycobacterium tuberculosis/isolement et purification
    Texte intégral

    Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system

    World Health Organization.
    Earlier and improved tuberculosis (TB) case detection - including smear-negative disease, often associated with HIV co-infection - as well as expanded capacity to diagnose multidrug-resistant tuberculosis (MDR-TB) are global priorities for TB control. Conventional laboratory methods are slow and cumberso...
    Tuberculose/diagnostic, Mycobacterium tuberculosis/isolement et purification, Infections à VIH/diagnostic, Sensibilité et spécificité, Tuberculose multirésistante, Rifampicine/pharmacologie
    Texte intégral